AltheaDx Revenue and Competitors

Location

$83.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AltheaDx's estimated annual revenue is currently $2M per year.(i)
  • AltheaDx's estimated revenue per employee is $77,500
  • AltheaDx's total funding is $83.4M.

Employee Data

  • AltheaDx has 26 Employees.(i)
  • AltheaDx grew their employee count by -30% last year.

AltheaDx's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
CEOReveal Email/Phone
3
SVP Sales and MarketingReveal Email/Phone
4
Senior Billing ManagerReveal Email/Phone
5
Clinical Laboratory SupervisorReveal Email/Phone
6
Regional Sales ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is AltheaDx?

AltheaDx is bringing cancer diagnostics into clinical use. The ultimate goal of AltheaDx is to win the war against cancer by reducing the time, risk, and cost of drug development and by providing comprehensive oncology testing services.

keywords:Biotechnology

$83.4M

Total Funding

26

Number of Employees

$2M

Revenue (est)

-30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AltheaDx News

2022-04-06 - Castle Biosciences Shares Fall 12% Following AltheaDx ...

Castle Biosciences Inc. shares fall roughly 12% to $40.51 a day after the company said it signed a definitive agreement to acquire AltheaDx...

2022-04-06 - Castle Biosciences to Acquire AltheaDx

AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx) testing services that are...

2022-04-06 - Castle Biosciences snaps up San Diego's AltheaDx to push precision medicine into mental health

San Diego startup AltheaDx, which developed a molecular test designed to guide therapy for depression and anxiety based on a patient's genetics,...

2021-08-18 - AltheaDx, Inc. expands its leadership team to address the need for precision medicine in Mental Health; appoints healthcare veterans Jonathan Yount as SVP of Sales and Croom Lawrence as SVP Marketing.

SAN DIEGO, Aug. 18, 2021 /PRNewswire/ -- AltheaDx, a commercial stage, precision medicine company with a leading pharmacogenomics (PGx) test for anxiety and depression, announced today the expansion of its commercial leadership team with the appointment of Jonathan Yount, SVP of Sales. Jonatha ...

2021-06-07 - AltheaDx, Inc. launches webinar series on Mental Health; Precision Diagnostics for depression and anxiety

SAN DIEGO, June 7, 2021 /PRNewswire/ -- AltheaDx, a commercial stage precision medicine company with a leading pharmacogenomics test (PGx) for depression and anxiety is launching a series of webinars. These educational sessions will focus on the use of PGx testing and associated implications o ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.9M26-4%N/A
#2
$1.8M26-24%$13.8M
#3
$1.7M26-38%$90.1M
#4
$3.8M26-51%$35.5M
#5
$2.6M26N/AN/A